We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
+17.61%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$447M
AUM Growth
-$161M
(-27%)
Cap. Flow
-$195M
Cap. Flow
% of AUM
-43.74%
Top 10 Holdings %
Top 10 Hldgs %
42.15%
Holding
164
New
40
Increased
22
Reduced
35
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bioceres Crop Solutions
BIOX
|
+$21M |
| 2 |
First Solar
FSLR
|
+$14.5M |
| 3 |
SentinelOne
S
|
+$8.86M |
| 4 |
Flex
FLEX
|
+$7.72M |
| 5 |
Stem
STEM
|
+$6.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MBII
Marrone Bio Innovations, Inc.
MBII
|
+$21.3M |
| 2 |
STKL
SunOpta
STKL
|
+$20.8M |
| 3 |
SolarEdge
SEDG
|
+$13.7M |
| 4 |
Wolfspeed
WOLF
|
+$9.1M |
| 5 |
Enovix
ENVX
|
+$7.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.23% |
| 2 | Healthcare | 15.62% |
| 3 | Utilities | 8.11% |
| 4 | Materials | 6.26% |
| 5 | Consumer Staples | 5.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STKL
1
DELISTED
SunOpta
STKL
| $24.4M | 5.46% |
2,678,500
-2,192,000
| -45% | -$20.8M |
|
|
2
First Solar
FSLR
$21.8B
| $23.9M | 5.36% |
181,000
+135,500
| +298% | +$14.5M |
|
3
Sunrun
RUN
$2.3B
| $22.6M | 5.07% |
817,100
+120,100
| +17% | +$3.74M |
|
|
4
Bioceres Crop Solutions
BIOX
$20.6M
| $22.3M | 4.99% |
+1,710,618
| New | +$21M |
|
|
AMPS
5
DELISTED
Altus Power
AMPS
| $20.5M | 4.58% |
1,858,500
+423,500
| +30% | +$4.04M |
|
|
CTLP
6
DELISTED
Cantaloupe
CTLP
| $19.9M | 4.45% |
5,717,121
-101,079
| -2% | -$554K |
|
7
CALL
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$289M
| $15.9M | 3.56% |
500,000
-2,000,000
| -80% | -$53.7M |
|
8
Harmonic Inc
HLIT
$1.2B
| $14.6M | 3.26% |
1,114,500
+238,000
| +27% | +$2.57M |
|
9
STAAR Surgical
STAA
$1.13B
| $12.3M | 2.76% |
175,000
-40,000
| -19% | -$3.42M |
|
10
Altimmune
ALT
$581M
| $11.8M | 2.65% |
927,950
-411,050
| -31% | -$6.07M |
|
11
Surgery Partners
SGRY
$2.04B
| $11.8M | 2.65% |
505,000
+155,000
| +44% | +$4.95M |
|
|
12
SentinelOne
S
$6.29B
| $11.2M | 2.51% |
439,000
+337,550
| +333% | +$8.86M |
|
13
Tenet Healthcare
THC
$22.6B
| $10.3M | 2.32% |
200,500
+10,300
| +5% | +$611K |
|
|
EVA
14
DELISTED
Enviva Inc.
EVA
| $9.61M | 2.15% |
160,000
+10,000
| +7% | +$672K |
|
15
Pacira BioSciences
PCRX
$1.05B
| $9.04M | 2.02% |
170,000
+35,000
| +26% | +$1.95M |
|
16
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$783B
| $8.93M | 2% |
25,000
-75,000
| -75% | -$29.8M |
|
17
Guardant Health
GH
$19B
| $8.88M | 1.99% |
165,000
+54,300
| +49% | +$2.79M |
|
18
Vistra
VST
$50.1B
| $8.77M | 1.96% |
417,500
-100,500
| -19% | -$2.43M |
|
|
19
Flex
FLEX
$41.5B
| $8.74M | 1.96% |
695,879
+604,449
| +661% | +$7.72M |
|
20
Atlassian
TEAM
$25.4B
| $8.13M | 1.82% |
38,600
-8,300
| -18% | -$1.94M |
|
21
EOG Resources
EOG
$74.4B
| $7.26M | 1.63% |
65,000
-20,300
| -24% | -$2.28M |
|
|
22
Stem
STEM
$47.7M
| $7M | 1.57% |
+26,250
| New | +$6.71M |
|
23
PayPal
PYPL
$51.4B
| $6.47M | 1.45% |
+75,000
| New | +$6.65M |
|
24
Iron Mountain
IRM
$37.4B
| $6.38M | 1.43% |
145,000
+30,000
| +26% | +$1.51M |
|
25
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $6M | 1.34% |
+75,450
| New | +$6.36M |
|
Similar funds
NA
MK
QIM
JVBC
TFP
UWPG
LOAMU
PHS
Ardsley Advisory Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Ardsley Advisory Partners held 164 positions worth $447M, down 27% from $608M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Ardsley Advisory Partners withdrew a net $195M in Q3 2022, closing 61 positions and reducing 35 holdings. Its most notable exit was Marrone Bio Innovations, Inc., an estimated $21.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 25% a quarter earlier, followed by Healthcare and Utilities.
Against the trend, Ardsley Advisory Partners opened a new position in Bioceres Crop Solutions worth $22.3M.
- Ardsley Advisory Partners's largest Q3 2022 buy was Bioceres Crop Solutions: 1,710,618 shares worth $22.3M.
- Ardsley Advisory Partners added most to First Solar in Q3 2022, an estimated $14.5M increase.
- Ardsley Advisory Partners's biggest Q3 2022 reduction was SunOpta, cutting an estimated $20.8M.
- Ardsley Advisory Partners fully exited Marrone Bio Innovations, Inc. in Q3 2022, selling an estimated $21.3M.
- Ardsley Advisory Partners's ten largest holdings make up 42% of its $447M portfolio in Q3 2022.
- Ardsley Advisory Partners opened 40 new positions and closed 61 in Q3 2022.
- Ardsley Advisory Partners's portfolio value fell 27% quarter-over-quarter to $447M.
Based on Ardsley Advisory Partners's 13F filing for Q3 2022, filed 14 Nov 2022.